Meridian Bioscience reported $449.72M in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Accelerate Diagnostics AXDX:US 81.16M 12.83M
Atrion ATRI:US 268.93M 1.3M
Becton, Dickinson and BDX:US $ 53866M 467M
Bio Rad Laboratories BIO:US $ 19953.38M 4835.82M
Cerulean Pharma CERU:US $ 48.81M 33.99M
Cerus CERS:US $ 218.95M 4.28M
Genmark Diagnostics GNMK:US $ 223.53M 8.94M
Luminex LMNX:US $ 819.03M 6.43M
Meridian Bioscience VIVO:US $ 449.72M 3.15M
Myriad Genetics MYGN:US $ 1335.9M 24.4M
Neogen NEOG:US $ 932.11M 11.91M
Orasure Technologies OSUR:US $ 455.76M 9.29M
Oxford Immunotec Global OXFD:US $ 210.5M 3.89M
Quidel QDEL:US $ 2106.38M 298.73M
Sientra SIEN:US $ 186.66M 3.87M
Staar Surgical STAA:US $ 324.6M 30.17M
Thermo Fisher Scientific TMO:US $ 73600M 5902M
Trinity Biotech TRIB:US $ 124.72M 11.26M
Utah Medical Products UTMD:US $ 119.75M 5.36M